Updated hourlyHourly refreshSun, Oct 4, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance
SUNNYVALE, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- News Summary Fortinet ® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, announced that it will hold a conference call to discuss its third quarter 2026 financial results on Wednesday, October 28, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
Oct 2 · 13:00·GlobeNewswire
Finance
Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Oct 2 · 13:00·GlobeNewswire
Finance
AB “Ignitis grupė” (hereinafter – the Group) announces that Kepler Cheuvreux, a leading independent European financial services company, with a strong presence in equity research and brokerage, has initiated sponsored research of the Group’s stock and published the initiation report.
Oct 2 · 13:00·GlobeNewswire
Finance · Healthcare
SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or the “Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it has entered into Sale and Purchase Agreements (the “SPAs”) to acquire the entire issued and paid-up share capital of (i) East Coast Podiatry Centre Pte. Ltd. (“ECPC”), which operates East Coast Podiatry Clinic (“ECP”), the leading podiatry-focused chain in Singapore; and (ii) Orchard Clinic Management Pte. Ltd. (“OCM”), which operates Orchard Clinic (“ORC”), a Singapore women’s health and wellness clinic (ECPC and OCM together, the “Target Group”), through its direct wholly-owned subsidiary, Cuprina Ho
Oct 2 · 13:00·GlobeNewswire
Finance · AI
COPENHAGEN, Denmark, October 2, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new immune data for AI-designed personalized cancer vaccine EVX-01 at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, taking place in Phoenix, Arizona, November 4-8, 2026.
Oct 2 · 13:00·GlobeNewswire
Finance
Rapid7 Launches Rapid7 Intelligence to Harness Threat Data Against Attackers
Oct 2 · 13:00·GlobeNewswire
Finance · Healthcare
BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (Nasdaq: ITOC) (the “Company”), a healthcare company developing digital medical technologies, today announced that at the extraordinary general meeting (the “EGM”) held on September 9, 2026, shareholders approved, among other matters, a 16-for-1 consolidation of the Company’s class A ordinary shares (the “Class A Ordinary Shares”) and class B ordinary shares (the “Class B Ordinary Shares”) (the “Share Consolidation”) and a related increase in authorized share capital. The Share Consolidation will combine every sixteen (16) issued and unissued Class A Ordinary Shares, par value US$0.0001 each, into one (1) Class A Ordinary Share, par value US$0.0016, and every sixteen (16) issued and unissued Class B Ordinary Shares, par
Oct 2 · 13:00·GlobeNewswire
Finance
Strengthens building envelope solutions with 50 years of waterproofing innovation
Oct 2 · 13:00·Newswire.com
Finance · Healthcare
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT ), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance and treat immune-mediated diseases and cancer, today announced two poster presentations at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting. The presentations address two distinct areas of cancer research: tumor-cell killing in checkpoint inhibitor–resistant colorectal cancer liver metastases and elimination of senescent tumor cells and fibroblasts.
Oct 2 · 13:00·GlobeNewswire
Finance · Healthcare
WINSTON-SALEM, N.C., Oct. 02, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today announced that the Company will present eight abstracts, including one oral presentation, at the upcoming American Society of Nephrology’s (ASN) Kidney Week being held from October 21-25, 2026, in Denver, CO.
Oct 2 · 13:00·GlobeNewswire
Finance
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Wildsky Resources Inc. (TSXV: WSK) (the "Company") is pleased to announce that it has signed a binding Letter of Intent (LOI) dated October 1, 2026 to acquire a 100% interest in the NewRidge Gold Project and to assume an option to purchase three adjacent Mining Claims (Claim No. 18035-18037 BM), located in Manicaland Province, Zimbabwe. This proposed arm's length acquisition represents a strategic milestone for WSK as it expands...
Oct 2 · 13:00·mlpr-newsfile
Finance
CHANHASSEN, Minn., Oct. 2, 2026 /PRNewswire/ -- Life Time Group Holdings, Inc. ("Life Time" or the "Company") (NYSE: LTH) today announced details for its third quarter 2026 earnings conference call. The Company will release its financial results before market open on Thursday, October 29,...
Oct 2 · 12:56·PR Newswire